文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 人文社科 > 哲学/历史 > The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins
侵权投诉

The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins

The role of OATP1B1 and BCRP in pharmacokinetics and DDI of novel statins

REVIEW

TheRoleofOATP1B1andBCRPinPharmacokineticsandDDIofNovelStatins

WenJinHua,WeiXiaoHua&HuJinFang

DepartmentofPharmacy,theFirstAf liatedHospitalofNanchangUniversity,Nanchang,China

Keywords

BCRP;DDIs;OATP1B1;pitavastatin;rosuvastatin;SNP.

Correspondence

WenJinHua,DepartmentofPharmacy,TheFirstAf liatedHospitalofNanchangUniversity,Nanchang,China.

Tel:+867916361194;Fax:+867916361195;E-mail:xyq2011@yahoo.cn

SUMMARY

TheaimofthisreviewistoprovideusefulinformationnotonlyforstudyingtheeffectofOATP1B1and/orBCRPgenemutationonpharmacokineticsofnovlestatinsofpitavastatinandrosuvastatinbutalsoforstudyingdrug–druginteractions(DDI)betweenthenovlestatinsandothersubstratesofOATP1B1and/orBCRP.Intra-andinter-ethnicdifferencesinpharmacokineticpro lesofclinicallyrelevantdrugsareimportantissuesreportedinmanypapersnotonlyforscenesofappropriatedrugusedinclinicalsettingsbutalsoforthoseofthedrugdevelopment.Pharmacogenomicsisextremelyusefulforunderstandingtheseracialdifferences.Recentpharmacogeneticsstudyhavedisclosedimpor-tantrolesofdrugtransportersinthepharmacokinetic(PK)pro lesofsomeclinicallyrelevantdrugs.Inthispresentation,weintroducesinglenucleotidepolymorphisms(SNPs)ofOATP1B1andBCRPandreviewthecontributionofgeneticpolymorphismsofthetransporterstothepharmacokineticsofdualsubstratesaspitavastatinandrosuvastatinfromrecentstudy.Atthesametime,theDDIsbetweenpitavastatinorrosuvastatinandotherdrughavebeenex-tensivelyconcernedbecauseofinhibitingOATP1B1-mediatedhepaticuptakeorBCRP-mediatedhepaticef uxofpitavastatinandrosuvastatin.ThisreviewsummarizedthecurrentstudiesabouttheroleofOATP1B1andBCRPinDDIsbetweenpitavastatinorrosuvastatinandotherclinicallyrelevantdrugs.TheroleofOATP1B1andBCRPgenemutationcanaffectthePKpro lesofpitavas-tatinandrosuvastatin.TheDDIsbetweenthenovlestatinsandothersubstratesofOATP1B1orBCRPmayoccurandcausechangeinthepharmacokineticofthenovlestatins.

doi:10.1111/j.1755-5922.2011.00290.x

Introduction

Transportersexpressedinvarioustissuesplayanimpor-tantroleindrugdispositionanddrugtransport.Drugsuptakeoref uxbytransportersisakeyprocessfortherelateddrugpharmacokinetics.TheHumanGeneNomenclatureCommittee(HGNC)hasclassi edtrans-portersbystandardizednamessuchasthesolutecarriersuperfamily(SLC)andATP-bindingcassettetransporters(ABC).Byregulatingthefunctionofsuchtransporters,itmaybepossibletoeventuallydevelopdrugswithidealpharmacokineticpro les.Thein uxandef uxtrans-porterslocatedeitheratthebasolateralorapicalmem-

braneinpolarizedcellswereclassi eddependonthedrugtransportmode.Forexample,intheliver,anuptaketransportersuchasorganicaniontransportingpolypep-tide1B1(formallyknownasOATP-CorOATP2,geneSLCO1B1/OATP1B1)mayextractitsdrugsubstratesfromtheportalbloodintohepatocytes,thenotherdrugtrans-porters,suchasbreastcancerresistanceprotein(BCRP/ABCG2)andmultidrugresistanceprotein1(MDR1,alsoknownasP-glycoprotein)maybeimportantinef uxofthemetaboliteorparentdrugsfromthehepatocyte[1].TherearemultipletransporterssuchasOATP1B1,OATP1B3,OATP2B1,OATP1A2,andBCRPmayinvolvedintheuptakeandef uxofdrugs.Thedrugtransporters

e234CardiovascularTherapeutics30(2012)e234–e241

ª2011BlackwellPublishingLtd

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email